Ropinirole Hydrochloride Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 5 mg

Reference Brands: Requip (USA)

Category: Neurology

Ropinirole Hydrochloride is available in Tablets and strengths such as 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ropinirole Hydrochloride is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ropinirole Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Ropinirole hydrochloride, marketed under the brand name Requip, is a non-ergot dopamine agonist used for the management of Parkinson’s disease and restless legs syndrome. As the hydrochloride salt form, it acts as a dopamine substitute by selectively binding to and activating dopamine D2 and D3 receptors in the caudate-putamen region of the brain, helping restore dopaminergic activity and improve motor function.

By targeting these receptors, ropinirole hydrochloride alleviates symptoms of Parkinson’s disease such as tremors, muscle rigidity, bradykinesia, and impaired coordination. It is available in immediate-release and extended-release oral formulations, allowing for flexible dosing tailored to patient needs.

Ropinirole therapy not only helps reduce motor dysfunction but also improves quality of life by addressing restless legs syndrome symptoms, including the uncomfortable sensations and the urge to move the legs, particularly during rest or at night. The medication is generally well-tolerated, though patients may experience side effects such as dizziness, nausea, hypotension, and somnolence. Through its targeted dopaminergic action, Requip offers a reliable and effective option for managing Parkinson’s disease and related neurological disorders.